HIV/AIDS: Prevalence, Prevention, and Treatment
HIV/AIDS Therapy CE for Pharmacists
Monograph
Are you a Pharmacy Tech? Check out the Pharmacy Tech version of this course.
Course Summary
The human immunodeficiency virus (HIV) is a retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV can significantly depress immune system function, leading progressively to AIDS. Antiretroviral therapy (ART) has reduced the morbidity and mortality associated with HIV-1 infection and AIDS, enabling HIV-infected individuals to live longer and have an improved quality of life. Advancements in ART and increasing availability of prevention options, such as oral preexposure prophylaxis (PrEP) and long-acting PrEP, have allowed many patients with HIV to achieve viral suppression. Nevertheless, HIV and AIDS are still serious health problems requiring federal and state resources.
Identify how HIV/AIDS is transmitted
Identify methods of prevention and precaution for HIV/AIDS transmission
Discuss treatment options for HIV/AIDS
Describe the types of co-occurring disorders that may be seen in patients diagnosed with HIV/AIDS
Describe HIV testing, confidentiality of test results for patients, and partner notification
Course Syllabus
I. Introduction
II. Prevalence of HIV/AIDS
III. Types and Stages of HIV Infection
A. HIV-1 and HIV-2
B. Stages of HIV Infection
IV. HIV Transmission
A. Potential Non-occupational Exposures to HIV
B. Occupational Exposure
V. Prevention of HIV Transmission
A. Non-occupational Prevention Strategies
B. Occupational Prevention Strategies
C. Post-exposure Prophylaxis for All HIV Exposures
D. PEPline Hotline
E. Risk of Needlestick Injuries in the Pharmacy Setting
VI. HIV Screening
A. Blood Test for Antibodies to HIV and HIV Antigen
B. Home Screening Tests
VII. Clinical Management
A. Pre-Exposure Prophylaxis (PrEP)
B. Case Study: Pre-Exposure Prophylaxis
VIII. AIDS and Co-occurring Disorders
A. Tuberculosis and Other Pulmonary Diseases
B. Cardiovascular Disease
C. Neurological Disease
D. Oral Lesions
E. Liver Disease
F. Hematologic Disease
G. Endocrine Disease
H. Dermatological Disease
I. Neoplastic Disease
J. Genitourinary Disease
K. AIDS-defining Diseases
IX. Case Study: HIV and Kidney Transplant
X. Brief Overview of Antiretroviral Therapy
A. ART Regimen Compliance Barriers
B. Case Study: ART and Viral Rebound in an Adolescent Male
C. Case Study: Prolonged Remission in a Child Born with HIV
XI. State Regulations for HIV/AIDS Testing
XII. New HIV Diagnosis and Partner Notification
XIII. Summary
- Read the course objectives and faculty planner disclosure
- Read the course material
- Complete the post-test with a minimum score of 70% and complete the course evaluation form.
- Results are automatically submitted to CPE Monitor
Faculty Planner Disclosure
The following individuals were involved in developing this activity: Pamela Sardo, PharmD, BS. None of the individuals involved in developing this activity has a conflict of interest or financial relationships regarding the subject matter. There are no financial relationships or commercial or financial support relevant to this activity to report or disclose by RxCe.com or any of the individuals involved in the development of this activity.
Unlabeled Use Disclosures
The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.
Computer Hardware/Software Requirements
Please ensure the device you plan to use meets these requirements and specifications:
- Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
- For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.
- Target Audience: Pharmacist
- Secondary Audiences: This educational activity is also for other healthcare professionals, such as nurses, physicians, or others who may be part of a healthcare team and may be interested in this educational topic. A healthcare team approach to patient care may be discussed in this activity, as applicable. No state board or professional organization has evaluated this activity to determine whether it meets the continuing education requirements of nurses, physicians, or other professions not listed under the “Target Audience” described above. Always verify with individual employers or supervisors whether they will accept this educational activity upon completion.
- Contact Hours: 3.0 (0.3 CEUs)
- Activity Release Date: 9/13/2025
- Activity Expiration Date: 9/13/2028
- Activity Type: Knowledge
- UAN: 0669-0000-25-119-H02-P
- Topic: HIV/AIDS Therapy
- CeBroker Number: 20-1328705
Faculty:
Preview the Materials:
RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.